A Markovian decision model of adaptive cancer treatment and quality of life
Bayer, P., Brown, J. S., Dubbeldam, J. & Broom, M. ORCID: 0000-0002-1698-5495 (2022). A Markovian decision model of adaptive cancer treatment and quality of life. Journal of Theoretical Biology, 551-552, article number 111237. doi: 10.1016/j.jtbi.2022.111237
Abstract
This paper develops and analyzes a Markov chain model for the treatment of cancer. Cancer therapy is modeled as the patient's Markov Decision Problem, with the objective of maximizing the patient's discounted expected quality of life years. Patients make decisions on the duration of therapy based on the progression of the disease as well as their own preferences. We obtain a powerful analytic decision tool through which patients may select their preferred treatment strategy. We illustrate the tradeoffs patients in a numerical example and calculate the value lost to a cohort in suboptimal strategies. In a second model patients may make choices to include drug holidays. By delaying therapy, the patient temporarily forgoes the gains of therapy in order to delay its side effects. We obtain an analytic tool that allows numerical approximations of the optimal times of delay.
Publication Type: | Article |
---|---|
Additional Information: | © 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Publisher Keywords: | Markov decision processes, Cancer therapy, Dynamic optimization, Quality of life |
Subjects: | Q Science > QA Mathematics R Medicine > RC Internal medicine R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
Departments: | School of Science & Technology School of Science & Technology > Mathematics |
SWORD Depositor: |
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (450kB) | Preview
Export
Downloads
Downloads per month over past year